Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cashflow Statement

MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹561 Cr₹504 Cr₹424 Cr₹338 Cr₹248 Cr
Adjustment ₹100 Cr₹69 Cr₹55 Cr₹74 Cr₹35 Cr
Changes In working Capital ₹-62 Cr₹-241 Cr₹-126 Cr₹-111 Cr₹-111 Cr
Cash Flow after changes in Working Capital ₹598 Cr₹333 Cr₹353 Cr₹300 Cr₹172 Cr
Cash Flow from Operating Activities ₹458 Cr₹207 Cr₹230 Cr₹237 Cr₹99 Cr
Cash Flow from Investing Activities ₹-248 Cr₹-49 Cr₹-141 Cr₹-259 Cr₹-84 Cr
Cash Flow from Financing Activities ₹-71 Cr₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr
Net Cash Inflow / Outflow ₹139 Cr₹93 Cr₹21 Cr₹176 Cr₹94 Cr
Opening Cash & Cash Equivalents ₹496 Cr₹403 Cr₹382 Cr₹206 Cr₹112 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-0.58 Cr--₹0.00 Cr-
Closing Cash & Cash Equivalent ₹634 Cr₹496 Cr₹403 Cr₹382 Cr₹206 Cr

Compare Cashflow Statement of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,772.7 Cr -2.7% -6.6% 72.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr 5.2% 4.3% 8% Stock Analytics
DIVIS LABORATORIES ₹273,565.0 Cr 3.6% 7.6% 50.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,332.0 Cr 3.4% 0.7% 32.6% Stock Analytics
DR REDDYS LABORATORIES ₹114,532.0 Cr 2.3% 14% 13.6% Stock Analytics
CIPLA ₹113,831.0 Cr 2% 6% -6.7% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.7%

-6.6%

72.4%

SENSEX

8.8%

10.9%

-4%


You may also like the below Video Courses